Doctor of Philosophy in the Field of Molecular Medicine

Specific admission requirements are shown on the Graduate Program Finder. Candidates must hold a bachelor’s degree in chemistry, biological sciences, or an approved related field.

The following requirements must be fulfilled:

The general requirements stated under Columbian College of Arts and Sciences, Graduate Programs.

The requirements for the Doctor of Philosophy Program.

Program-specific curriculum:

The biomedical sciences core curriculum:
BMSC 8210Genes to Cells
BMSC 8212Developmental Cell Biology and Systems Physiology
BMSC 8216Scientific Writing, Presentation Skills, and Seminar Planning
BMSC 8217Ethics and Grant Writing
BMSC 8218Career Options in the Biomedical Sciences
3 credits of the following:
BMSC 8215Lab Rotations
Neuroscience specialization:
First-year required courses
ANAT 6160Clinically Oriented Human Functional Neuroanatomy
and one of the following:
BMSC 8230Molecular Basis of Human Disease
PHAR 6116Pharmacogenomics and Personalized Medicine
MICR 8210Infection and Immunity
Second-year required courses
MMED 8214Molecular Medicine Seminar (taken twice)
MMED 8281Molecular Pharmacology and Neurobiology of Excitable Tissues
MMED 8282Neural Development and Neurodevelopmental Disorders
MMED 8283Current Topics in Neuroscience
Elective courses
MMED 8221The Basic Science of Oncology
MMED 8222Molecular Oncology
PHAR 6205Pharmacology
MMED 8998Advanced Reading and Research
Oncology specialization:
First-year required courses
Two of the following
BMSC 8230Molecular Basis of Human Disease
PHAR 6116Pharmacogenomics and Personalized Medicine
MICR 8210Infection and Immunity
ANAT 6160Clinically Oriented Human Functional Neuroanatomy
Second-year required courses
MMED 8214Molecular Medicine Seminar (taken twice)
MMED 8221The Basic Science of Oncology
MMED 8222Molecular Oncology
Elective courses
MMED 8281Molecular Pharmacology and Neurobiology of Excitable Tissues
MMED 8282Neural Development and Neurodevelopmental Disorders
MMED 8283Current Topics in Neuroscience
MMED 8999Dissertation Research
PHAR 6205Pharmacology
Pharmacology specialization:
First-year required courses
PHAR 6116Pharmacogenomics and Personalized Medicine
One of the following
BMSC 8230Molecular Basis of Human Disease
MICR 8210Infection and Immunity
ANAT 6160Clinically Oriented Human Functional Neuroanatomy
Second-year required courses
MMED 8214Molecular Medicine Seminar (taken twice)
PHAR 6205Pharmacology
PHAR 6206Advanced Pharmacology
Elective courses
MMED 8281Molecular Pharmacology and Neurobiology of Excitable Tissues
MMED 8282Neural Development and Neurodevelopmental Disorders
MMED 8283Current Topics in Neuroscience
MMED 8221The Basic Science of Oncology
MMED 8222Molecular Oncology
MMED 8998Advanced Reading and Research
Electives for all specializations
BMSC 8231Introduction to Genomics, Proteomics, and Bioinformatics
BMSC 8233Integrative Bioinformatics
BMSC 8234Seminar in Systems Biology
BMSC 8235Applied Biostatistics for Basic Research
MICR 6212Pathogenic Bacteriology
MICR 6230Molecular & Cellular Immunolog
MICR 6233Virology
MICR 6236Fundamentals in Geonomics and Proteomics I
MICR 8270Advanced Topics in Immunology
HSCI 6263Biostatistics Translational Research
PHAR 6206Advanced Pharmacology

Research fields

  • Neuroscience—developmental neurobiology, neurodevelopmental disorders, white matter diseases, neurobehavioral disorders of childhood, brain injury and recovery, sensory processing, neurotransmitter systems, neurological channelopathies
  • Oncology— cancer chemotherapy and mechanisms of resistance, tumor cell biology and metabolism, gene regulation, oncogenes and tumor suppressor genes, growth factors, immunotherapy, development of immunological and molecular markers for diagnosis and detection, tumor immunology, epidemiology and prevention, cancer and AIDS, mechanisms of metastasis, transgenic models of cancer, genomics and proteomics
  • Pharmacology—neuropharmacology, cardiovascular physiology and pharmacology, biochemical and molecular pharmacology, molecular, genomic, and computational approaches for elucidating genetic networks underlying disease processes, such as cancer progression (i.e., metastatic potential, epithelial-mesenchymal transition)